AGNC Investment Analyst Price Targets

Wall Street analyst price targets and consensus rating for AGNC Investment (AGNC).

Price Target Range — 13 Quarters

Analyst Consensus — 14 Analysts

5Buy

9Hold

Consensus RatingNeutral# Analysts14Avg. Consensus PT$10Upside to Avg. PT+14.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 23, 2026	JP Morgan	Richard Shane	PT Raise	Neutral	$8→$9
Oct 21, 2026	RBC Capital	Kenneth S. Lee	PT Cut	Outperform	$12→$10
Oct 21, 2026	Wells Fargo	Donald Fandetti	PT Cut	Overweight	$11→$10
Oct 21, 2026	Barclays	Terry Ma	PT Cut	Equal-Weight	$10→$9
Oct 9, 2026	Piper Sandler	Crispin Love	PT Cut	Overweight	$12→$10
Jul 23, 2026	Wells Fargo	Donald Fandetti	PT Cut	Overweight	$12→$11
Jul 22, 2026	JP Morgan	Richard Shane	PT Cut	Neutral	$12→$11
Jul 22, 2026	Keefe, Bruyette & Woods	Bose George	PT Cut	Market Perform	$12→$11
Jul 17, 2026	Compass Point	Merrill Ross	Downgrade	Buy→Neutral	$13→$12
Jul 17, 2026	JP Morgan	Richard Shane	Downgrade	Overweight→Neutral	$10→$10
Jul 2, 2026	Piper Sandler	Crispin Love	PT Raise	Overweight	$12→$12
Apr 24, 2026	UBS	Marissa Lobo	PT Raise	Neutral	$11→$11
Apr 16, 2026	JP Morgan	Richard Shane	PT Cut	Overweight	$12→$11
Apr 2, 2026	Piper Sandler	Crispin Love	PT Cut	Overweight	$13→$11
Jan 29, 2026	RBC Capital	Kenneth S. Lee	PT Raise	Outperform	$11→$13
Jan 29, 2026	Wells Fargo	Donald Fandetti	PT Raise	Overweight	$10→$12
Jan 29, 2026	Keefe, Bruyette & Woods	Bose George	Downgrade	Outperform→Market Perform	$11→$12
Jan 22, 2026	Jones Trading	Jason Weaver	Downgrade	Buy→Hold	—
Jan 15, 2026	Piper Sandler	Crispin Love	PT Raise	Overweight	$11→$12
Jan 6, 2026	Barclays	Mark Devries	PT Raise	Equal-Weight	$9→$10

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on AGNC Investment, Raises Price Target to $8.5

JP Morgan analyst Richard Shane maintains AGNC Investment (NASDAQ:AGNC) with a Neutral and raises the price target from $8 to $8.5.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on AGNC Investment, Lowers Price Target to $10

RBC Capital analyst Kenneth S. Lee maintains AGNC Investment (NASDAQ:AGNC) with a Outperform and lowers the price target from $12 to $10.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on AGNC Investment, Lowers Price Target to $10

Wells Fargo analyst Donald Fandetti maintains AGNC Investment (NASDAQ:AGNC) with a Overweight and lowers the price target from $11 to $10.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on AGNC Investment, Lowers Price Target to $9

Barclays analyst Terry Ma maintains AGNC Investment (NASDAQ:AGNC) with a Equal-Weight and lowers the price target from $10 to $9.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on AGNC Investment, Lowers Price Target to $10

Piper Sandler analyst Crispin Love maintains AGNC Investment (NASDAQ:AGNC) with a Overweight and lowers the price target from $12 to $10.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on AGNC Investment, Lowers Price Target to $11

Wells Fargo analyst Donald Fandetti maintains AGNC Investment (NASDAQ:AGNC) with a Overweight and lowers the price target from $12 to $11.

Benzinga Newsdesk

AGNC Investment Corp

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

AGNC Investment Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on AGNC Investment, Raises Price Target to $8.5

PRO
RBC Capital Maintains Outperform on AGNC Investment, Lowers Price Target to $10

PRO
Wells Fargo Maintains Overweight on AGNC Investment, Lowers Price Target to $10

PRO
Barclays Maintains Equal-Weight on AGNC Investment, Lowers Price Target to $9

PRO
Piper Sandler Maintains Overweight on AGNC Investment, Lowers Price Target to $10

PRO
Wells Fargo Maintains Overweight on AGNC Investment, Lowers Price Target to $11

People Also Watch

People Also Watch

AGNC Investment Corp

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

AGNC Investment Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJP Morgan Maintains Neutral on AGNC Investment, Raises Price Target to $8.5

PRORBC Capital Maintains Outperform on AGNC Investment, Lowers Price Target to $10

PROWells Fargo Maintains Overweight on AGNC Investment, Lowers Price Target to $10

PROBarclays Maintains Equal-Weight on AGNC Investment, Lowers Price Target to $9

PROPiper Sandler Maintains Overweight on AGNC Investment, Lowers Price Target to $10

PROWells Fargo Maintains Overweight on AGNC Investment, Lowers Price Target to $11

People Also Watch

People Also Watch

PRO
JP Morgan Maintains Neutral on AGNC Investment, Raises Price Target to $8.5

PRO
RBC Capital Maintains Outperform on AGNC Investment, Lowers Price Target to $10

PRO
Wells Fargo Maintains Overweight on AGNC Investment, Lowers Price Target to $10

PRO
Barclays Maintains Equal-Weight on AGNC Investment, Lowers Price Target to $9

PRO
Piper Sandler Maintains Overweight on AGNC Investment, Lowers Price Target to $10

PRO
Wells Fargo Maintains Overweight on AGNC Investment, Lowers Price Target to $11